What is Tempest Therapeutics, Inc. Common Stock's Market Cap?

Tempest Therapeutics, Inc. Common Stock's Market Cap is $15.8M, based on as-reported figures from SEC (XBRL) filings.

What is Tempest Therapeutics, Inc. Common Stock's Enterprise Value?

Tempest Therapeutics, Inc. Common Stock's Enterprise Value is $15.0M, based on as-reported figures from SEC (XBRL) filings.

What is Tempest Therapeutics, Inc. Common Stock's EV / EBITDA?

Tempest Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Tempest Therapeutics, Inc. Common Stock's Net Income (TTM)?

Tempest Therapeutics, Inc. Common Stock's Net Income (TTM) is -$40.5M, based on as-reported figures from SEC (XBRL) filings.

What is Tempest Therapeutics, Inc. Common Stock's EBITDA?

Tempest Therapeutics, Inc. Common Stock's EBITDA is -$40.4M, based on as-reported figures from SEC (XBRL) filings.

What is Tempest Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Tempest Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.53, based on as-reported figures from SEC (XBRL) filings.

What is Tempest Therapeutics, Inc. Common Stock's Net Debt?

Tempest Therapeutics, Inc. Common Stock's Net Debt is -$779.0K, based on as-reported figures from SEC (XBRL) filings.

Tempest Therapeutics, Inc. Common Stock (TPST) Financial Statements

Tempest Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002NDK348

XNAS · usd

0.99▼ 0.04 (-4.16%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.03

Day's Range0.98 – 1.03

52-Week Range0.84 – 12.23

Volume196.7K

Avg Volume225.2K

Share Statistics

Shares Outstanding

Employees4

ExchangeXNAS

Listed2021-06-28

Share count as of June 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Tempest Therapeutics, Inc. Common Stock (TPST)

What is Tempest Therapeutics, Inc. Common Stock's Market Cap?: Tempest Therapeutics, Inc. Common Stock's Market Cap is $15.8M, based on as-reported figures from SEC (XBRL) filings.
What is Tempest Therapeutics, Inc. Common Stock's Enterprise Value?: Tempest Therapeutics, Inc. Common Stock's Enterprise Value is $15.0M, based on as-reported figures from SEC (XBRL) filings.
What is Tempest Therapeutics, Inc. Common Stock's EV / EBITDA?: Tempest Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tempest Therapeutics, Inc. Common Stock's Net Income (TTM)?: Tempest Therapeutics, Inc. Common Stock's Net Income (TTM) is -$40.5M, based on as-reported figures from SEC (XBRL) filings.
What is Tempest Therapeutics, Inc. Common Stock's EBITDA?: Tempest Therapeutics, Inc. Common Stock's EBITDA is -$40.4M, based on as-reported figures from SEC (XBRL) filings.
What is Tempest Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Tempest Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.53, based on as-reported figures from SEC (XBRL) filings.
What is Tempest Therapeutics, Inc. Common Stock's Net Debt?: Tempest Therapeutics, Inc. Common Stock's Net Debt is -$779.0K, based on as-reported figures from SEC (XBRL) filings.